The stake is too small to signal conviction or influence. Monitor for any future increases that could indicate a larger position or a potential conversion to an activist 13D filing.
ADCT drugs
ADCT drug pipeline →Price Chart
How similar events traded
Executive Summary
Prosight Management, LP filed an amended Schedule 13G disclosing a passive stake of 0.31% (399,900 shares) in ADC Therapeutics as of September 30, 2026. This is a new filing by a different investor compared to the prior 9.99% stake from Bain Capital, and the stake is very small relative to the company's market cap.
Key Financial Metrics
Key Facts
- Prosight Management, LP disclosed beneficial ownership of 399,900 common shares of ADC Therapeutics as of September 30, 2026.
- The stake represents 0.31% of shares outstanding based on 127,667,695 shares as of August 3, 2026.
- This is an amendment to a Schedule 13G filed under Rule 13d-1(c), indicating a passive investment intent.
- The filing is by a new filer (Prosight Management), not an update to the prior Bain Capital or Redmile Group stakes.
Financial Impact
Stake value approximately $0.6M based on $204M market cap and 0.31% ownership.
Risk Factors
- No material risks identified from this filing alone.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001617201-26-000007 |
| Document: 0001617201-26-000007-index.html | 0001617201-26-000007 |
| Document: 0001617201-26-000007.txt | 0001617201-26-000007 |
Track record
14 reports on ADCT
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Viewing Entry $1.41 Now $1.25 −11.35% settles Dec 15
- Nov 9, 20267d ago S-3 Neutral 3/10 Entry $1.51 Now $1.25 −17.22% settles Dec 9
- Nov 9, 20267d ago 8-K Neutral 4/10 Entry $1.67 Now $1.25 −25.15% settles Dec 8
- Nov 4, 202612d ago 8-K Mixed 6/10 Entry $1.64 Now $1.25 −23.78% settles Dec 4
- Nov 3, 202613d ago S-4 Neutral 3/10 Entry $1.72 Now $1.25 −27.33% settles Dec 3
- Oct 29, 202618d ago SC 13G Neutral 4/10 Entry $1.53 Now $1.25 −18.30% settles Nov 30
- Oct 13, 20264w ago 8-K Bullish 7/10 Entry $1.70 to $1.51 Now $1.25 −26.47% ▼ −11.18% −7.57% vs SPY
- Aug 6, 202614w ago Press Release Neutral 1/10 Entry $1.13 to $1.32 Now $1.25 +10.62% ▲ +16.81% +16.21% vs SPY
- Jul 2, 202619w ago 8-K Neutral 2/10 Entry $1.19 to $1.11 Now $1.25 +5.04% ▼ −6.72% −6.31% vs SPY
- Jun 3, 202623w ago 8-K Mixed 6/10 Entry $1.32 to $1.19 Now $1.25 −5.30% ▼ −9.85% −8.48% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers